21 May 2009
Individualization of immunosuppressive therapy
B D KahanAnn Transplant 2009; 14(1): 20-20 :: ID: 880272
Abstract
This "Meet the Professor" discussion session is divided into four segments:
pre-morbid donor features (5 minutes), pre-transplant morbid donor events
(5 minutes), pre-transplant characteristics of potential recipients (10 minutes), and post-transplant recipient events (15 minutes). Each section will include a brief presentation and questions. The pre-morbid donor features include age over 50 years, pharmacogenomics, kidney size, and concomitant diseases. The morbid donor events include the etiology of death, preretrieval pathophysiologic events and intraoperative events. The pretransplant recipient characteristics are gender, age, ethnicity, medical regimen, pharmacogenomics, unrecognized malignancy/infection, HLA mismatch, socioeconomic education level, donor source, and immune responder status. The post-transplant recipient events include cold ischemia time, concomitant drug therapies, complications, chronic allograft disease, rejection episodes and non-compliance. Literature citations will be provided and informal discussion offered after the session.
Keywords: immunosuppressive therapy
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860